Education
About Us
Working with TipRanks
Follow Us
Jeryl Hilleman Insider Profile
4 Followers
Jeryl Hilleman, CFO at Intersect ENT, holds 24.14K shares in SI-Bone (Ticker: SIBN), holds 6.59K shares in NovoCure (Ticker: NVCR), holds 1.00K shares in Minerva Neurosciences (Ticker: NERV).
Jeryl Hilleman Intersect ENT (XENT)CFO
Intersect ENT (XENT)
CFO
Not Ranked
Jeryl Hilleman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jeryl Hilleman holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 27, 2019 - Jun 27, 2020
Return:-35.80%
The most profitable trade made by Jeryl Hilleman
Jeryl Hilleman's Trading History
Intersect ENT
May 08, 2019
―
Uninformative Buy
―
$1.24M
Minerva Neurosciences
Jun 27, 2019
Director
Informative Buy
5.25K
$1.64K
NovoCure
Jun 06, 2024
Director
Uninformative Buy
―
$132.99K
SI-Bone
Jun 27, 2024
Director
Uninformative Buy
―
$387.69K
Talis Biomedical
―
Director
―
―
HilleVax, Inc
―
Director
―
―
Cutera
―
Director
―
―
XenoPort
Jul 06, 2016
―
Uninformative Sell
178.15K
$143.82K
Amyris
May 23, 2011
―
Uninformative Sell
100.77K
$106.87
Ocera Therapeutics
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Jeryl Hilleman's performance on stock
You May Also Like
Jeryl Hilleman insider profile FAQ
What is the percentage of profitable transactions made by Jeryl Hilleman?
The percentage of profitable transactions made by Jeryl Hilleman is ―.
What is the average return per transaction made by Jeryl Hilleman?
The average return per transaction made by Jeryl Hilleman is ―.
What stocks does Jeryl Hilleman hold?
Jeryl Hilleman holds: XENT, NERV, NVCR, SIBN, TLIS, HLVX, CUTR, XNPT, AMRSQ, OCRX stocks.
What was Jeryl Hilleman’s latest transaction?
Jeryl Hilleman latest transaction was an Uninformative Buy of ―.
What was Jeryl Hilleman's most profitable transaction?
Jeryl Hilleman’s most profitable transaction was an Informative Buy of NERV stock on June 27, 2019. The return on the trade was -35.80%.
What is Jeryl Hilleman's role in Intersect ENT?
Jeryl Hilleman's role in Intersect ENT is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.